📰 Alacyclovir News
Page 14 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
January 25, 2022
The US health regulator has expanded its approval for remdesivir.
January 25, 2022
Bamlanivimab/etesevimab and casirivimab/imdevimab are highly unlikely to be active against the Omicron variant, which now makes up virtually all cases of COVID-19 in the United States, the FDA says.
January 21, 2022
Herpes zoster ophthalmicus can be devastating. Dr Rapuano urges all ophthalmologists to discuss the zoster vaccine with their patients.
January 20, 2022
Benefit finding is a skill among some of the more resilient people whose lives have been upended by COVID-19, and experts explain how it can help others.
January 18, 2022
Donald Trump falsely declared in a weekend rally that public health authorities are denying the COVID-19 vaccine to White people because of their race.
January 18, 2022
Gilead Sciences said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over 2 years by a network of drug distributors and suppliers.
January 12, 2022
Shares in PharmaMar jumped almost 20% on Tuesday after the Spanish drugmaker said lab trials suggested its Plitidepsin drug was effective against the main COVID-19 variants, including the highly contagious Omicron.
January 5, 2022
The Biden administration has doubled its order for Pfizers oral COVID-19 antiviral treatment, the company and the White House said on Tuesday.
January 4, 2022
Pfizers antiviral drug Paxlovid, which contains a combination of PF-07321332 and ritonavir, has been approved by the MHRA for use in those with mild to moderate COVID-19 at risk of developing more severe disease.
December 27, 2021
A Japanese health ministry panel recommended approval of the COVID-19 antiviral pill developed by Merck last week, part of plans by Prime Minister Fumio Kishida to roll out new treatments by years end.